Zobrazeno 1 - 10
of 22
pro vyhledávání: '"James Otvos"'
Autor:
John T. Wilkins, Hongyan Ning, Allan Sniderman, Neil Stone, James Otvos, David R. Jacobs, Jr., Ravi Shah, Venkatesh L. Murthy, Jamal Rana, Norrina Allen, Donald M. Lloyd-Jones
Publikováno v:
Journal of Lipid Research, Vol 63, Iss 12, Pp 100299- (2022)
The cumulative exposure to apolipoprotein B (apoB)-containing lipoproteins in the blood during early adult life is a central determinant of atherosclerotic cardiovascular disease risk. To date, the patterns and rates of change in apoB through early a
Externí odkaz:
https://doaj.org/article/8c10e7e1cae447dda2a3d11d5afcdecb
Autor:
Paulette D Chandler, Akintunde O Akinkuolie, Deirdre K Tobias, Patrick R Lawler, Chungying Li, M Vinayaga Moorthy, Lu Wang, Daniel A Duprez, David R Jacobs, Robert J Glynn, James Otvos, Margery A Connelly, Wendy S Post, Paul M Ridker, JoAnn E Manson, Julie E Buring, I-Min Lee, Samia Mora
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165615 (2016)
Acute phase proteins highlight the dynamic interaction between inflammation and oncogenesis. GlycA, a novel nuclear magnetic resonance (NMR) inflammatory marker that identifies primarily circulating N-acetyl glycan groups attached to acute phase prot
Externí odkaz:
https://doaj.org/article/1c9f2f58a9a34094ac24619ce622599d
Autor:
Herman J. Kempen, Dorota B. Schranz, Bela F. Asztalos, James Otvos, Elias Jeyarajah, Denise Drazul-Schrader, Heidi L. Collins, Steven J. Adelman, Peter L. J. Wijngaard
Publikováno v:
Journal of Lipids, Vol 2014 (2014)
MDCO-216 is a complex of dimeric ApoA-IMilano and palmitoyl oleoyl phosphatidylcholine (POPC), previously shown to reduce atherosclerotic plaque burden. Here we studied the effect of incubation of human plasma or serum with MDCO-216 on cholesterol ef
Externí odkaz:
https://doaj.org/article/afeacca9b1f14e15b754edbc42c22a3e
Autor:
Elad Shemesh, Parag Anilkumar Chevli, Tareq Islam, Charles A German, James Otvos, Joseph Yeboah, Fatima Rodriguez, Christopher deFilippi, Joao A C Lima, Michael Blaha, Ambarish Pandey, Muthiah Vaduganathan, Michael D Shapiro
Publikováno v:
European Heart Journal. 44:1636-1646
Aims Ketone bodies (KB) are an important alternative metabolic fuel source for the myocardium. Experimental and human investigations suggest that KB may have protective effects in patients with heart failure. This study aimed to examine the associati
Autor:
Parag Anilkumar Chevli, Elad Shemesh, Tareq Islam, Charles German, Michael Blaha, James Otvos, Fatima Rodriguez, Joseph Yeboah, Michael D. Shapiro
Publikováno v:
Journal of the American College of Cardiology. 79:1460
Autor:
David M Tehrani, Yanglu Zhao, Michael Blaha, Samia Mora, Rachel Mackey, Erin Michos, Matthew Budoff, William Cromwell, James Otvos, Paul Rosenblit, Nathan Wong
Publikováno v:
Circulation. 132
Background: A more important role of both low and density lipoprotein (LDL-P and HDL-P) than cholesterol (LDL-C and HDL-C) concentration in predicting coronary heart disease (CHD) has been noted. However, the role of these factors and extent of parti
Autor:
Russell Tracy, Daniel Duprez, Rachel H. Mackey, David R. Jacobs, Otto A. Sanchez, James Otvos
Publikováno v:
Journal of the American College of Cardiology. 65(10)
Autor:
Kirk U. Knowlton, J. Brent Muhlestein, Oxana Galenko, Margery Connelly, Donald L. Lappé, Jeffrey L. Anderson, Heidi May, James Otvos
Publikováno v:
Journal of the American College of Cardiology. 69:1069
Background: GlycA, a novel marker of inflammation, has been associated with future CV risk among patients with or without pre-existing coronary artery disease (CAD). Whether GlycA is an independent and additive predictor of high sensitivity C-reactiv
Autor:
Daniel Duprez, James Otvos, Kenneth Feingold, Philip Greenland, Myron D Gross, Jao Lima, James D Neaton, Otto A Sanchez, Russel Tracy, David Jacobs
Publikováno v:
Circulation. 130
In vitro studies have demonstrated that high density lipoprotein particles (HDL-P) antagonize inflammatory processes. We studied the predictive value of HDL-P and inflammatory markers for incident cardiovascular disease (CVD) and non-CVD, non-cancer,
Autor:
Herman J Kempen, Dorota B Schranz, Bela Asztalos, Elias Jeyarajah, James Otvos, Denise Drazul-Schrader, Heidi L Collins, Steven J Adelman
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 34
MDCO216 is a complex of dimeric apoA-IMilano and POPC, shown to reduce atherosclerotic plaque burden. Here we studied the effect of incubation of human plasma or serum with MDCO216 on cholesterol efflux capacity from J774 cells, on prebeta-1 HDL and